Henry Schein, Inc. (LON:0L3C)
London · Delayed Price · Currency is GBP · Price in USD 81.95
+0.88 (1.08%)
At close: Feb 12, 2026
Henry Schein Market Cap
Henry Schein has a market cap or net worth of 7.05 billion as of February 12, 2026. Its market cap has decreased by -7.62% in one year.
Market Cap
7.05B
Enterprise Value
10.60B
Revenue
9.65B
Ranking
n/a
PE Ratio
24.17
Stock Price
81.95
Market Cap Chart
Since November 3, 1995, Henry Schein's market cap has increased from 263.64M to 7.05B, an increase of 2,573.47%. That is a compound annual growth rate of 11.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 7.05B | 6.62% |
| Dec 31, 2025 | 6.61B | -4.07% |
| Dec 31, 2024 | 6.89B | -10.77% |
| Dec 29, 2023 | 7.72B | -14.04% |
| Dec 30, 2022 | 8.99B | 13.16% |
| Dec 31, 2021 | 7.94B | 13.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Convatec Group | 4.37B |
| Hikma Pharmaceuticals | 3.43B |
| Genus | 2.09B |
| HUTCHMED (China) | 1.88B |